Zhejiang Haisen Pharmaceutical Co. Ltd. A

SHE:001367 China Drug Manufacturers - General

Market Cap

$473.42 Million

CN¥3.47 Billion CNY

Market Cap Rank

#16612 Global

#4390 in China

Share Price

CN¥22.80

Change (1 day)

-1.51%

52-Week Range

CN¥20.08 - CN¥32.24

All Time High

CN¥54.33

Zhejiang Haisen Pharmaceutical Co. Ltd. A - Asset Resilience Ratio

Latest as of June 2025: 32.14%

Zhejiang Haisen Pharmaceutical Co. Ltd. A (001367) has an Asset Resilience Ratio of 32.14% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥490.00 Million

Cash + Short-term Investments

Total Assets

CN¥1.52 Billion

All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2021–2021)

This chart shows how Zhejiang Haisen Pharmaceutical Co. Ltd. A's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Zhejiang Haisen Pharmaceutical Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥490.00 Million	32.14%
Total Liquid Assets	CN¥490.00 Million	32.14%

Asset Resilience Insights

Very High Liquidity: Zhejiang Haisen Pharmaceutical Co. Ltd. A maintains exceptional liquid asset reserves at 32.14% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.